Skip to main content

Table 2 Summary of studies reporting DNA methylation in bipolar disorder

From: DNA methylation in peripheral tissue of schizophrenia and bipolar disorder: a systematic review

Ref.

N

Mean age (SD)

Sex (F %)

Method

Subgroup analyses /covariates

RESULTS: methylation loci

 

BD

HC

BD

HC

BD

HC

   

Bromberg et al., 2009 [42]

49

27

39 (13)

42 (10)

41

37

Radiolabeled [3H] cytosine-extension assay a, c, d

Medication (valproate) h, sex h, smoking h, duration of illness h, family history of BD h

No global methylation differences h

Carlberg et al., 2014 [43]

60

278

42 (15)

32 (4)

45

62

MethyLight b, c, d

Age g, gender h, clinical variables, genotype h

No difference in methylation of BDNF (exon I promoter) h

D’Addario et al., 2012 [44]

94

52

52 (12)

-

60

-

Fluorescence-based real-time PCR b, c, d

Medication e, BD-I compared to BD-II h, mood state h

Hypermethylation of BDNF (exon I promoter) e only in BD-II;

Higher methylation associated with mood stabiliser and antidepressants, but lower for lithium and valproate

Dell’Osso et al., 2014 [45]

111

44

-

-

-

-

Fluorescence-based real-time PCR b, c, d

Age h, sex h, mood state e, medication, BD-I compared to BD-II

Hypermethylation of BDNF (exon I promoter) e in BD-II compared to BD-I;

Higher methylation in depressed compared to manic/mixed states; Higher methylation in BD-II males with increasing age

Kaminsky et al., 2012 [46]

370

382

43 (11)

42 (6)

58

55

Pyrosequencing b, c, d

Age e, sex, genotype f, medication (mood stabiliser) e

HCG9 (first exon extending into the first intron) f in BD (when controlling for age and genotype);

Higher methylation in BD/HC with increasing age;

Lower methylation in GG allele compared to GA allele carriers;

Higher mood stabiliser dose increases methylation towards HC levels

Kuratomi et al., 2008 [47]

23

18

57 (11)

46 (12)

52

33

Pyrosequencing b, c, d

Age h, sex e, medication (valproate) h, BD-I compared to BD-II f

Differential methylation of SMS (5'region) g, higher methylation for females in BD-I/II group compared to HC;

Hypomethylation of PPIEL (promoter and 5'region) f for BD-II compared to BD-I;

No difference in methylation of PIP5KL1 h, ARMC3 h

Sugawara et al., 2011 [48]

20

20

39 (13)

39 (9)

60

20

Pyrosequencing b, c, d

-

Differential methylation of SLC6A4 (promoter) g, higher methylation in CpG 3 and 4 for BD compared to HC

  1. BD bipolar disorder, HC healthy control, N sample number, F female, SD standard deviation, PCR, polymerase chain reaction. Genes: BDNF brain-derived neurotrophic factor, HCG9 human leukocyte antigen complex group 9, SMS spermine synthase, PPIEL peptidylprolyl isomerase E-like, PIP5KL1 phosphatidylinositol-4-phosphate 5-kinase-like 1, ARMC3 armadillo repeat containing 3, SLC6A4 serotonin transporter solute carrier family 6 member 4
  2. Study type
  3. a global DNA methylation
  4. b candidate gene study
  5. Tissue type
  6. c blood
  7. Measure of Methylation
  8. d percentage
  9. Results
  10. e significant hypermethylation
  11. f significant hypomethylation
  12. g significant differentially methylated
  13. h no significant differences